The pro-peptide argument isn't that these substances are proven cures, but that a regulated "white market" is safer than the current gray market. By moving production to GMP-certified compounding pharmacies under FDA oversight, the goal is to reduce harm from a dodgy, unregulated supply chain that already exists.

Contrary to the dominant media narrative, neuroscientist Carl Hart asserts that the vast majority of people using even the most vilified drugs are not addicted. They successfully manage their parental, occupational, and social responsibilities, challenging the idea that use inevitably leads to ruin.

Legalization frameworks can actively repair past harms by automatically expunging criminal records and reinvesting a percentage of tax revenue directly into communities disproportionately targeted by the War on Drugs, funding public health, education, and re-entry programs.

Carl Hart argues scientific research on drugs is systemically biased. The primary funding body, the National Institute on Drug Abuse, is mission-bound to focus almost exclusively on negative effects. This incentivizes researchers, journal editors, and reviewers to find and emphasize harm, creating a biased echo chamber.

Neuroscientist Carl Hart refutes the idea that addiction is a random risk for any user. He argues it's highly predictable, correlating strongly with pre-existing conditions like psychiatric illness, unemployment, lack of responsibility skills, and immense external pressures, not simply with drug exposure.

Professor Carl Hart clarifies that overdoses and addiction are distinct phenomena that are often conflated. Overdose deaths are more common among inexperienced users who lack tolerance or knowledge, often due to tainted drugs. In contrast, experienced, addicted users are statistically less likely to die from an overdose.

Most opioid-related deaths are not from an overdose of a single, pure substance. They result from user ignorance about two key factors: lethal contaminants like fentanyl mixed into the supply, and the exponentially increased risk of combining opioids with other sedatives like alcohol or benzodiazepines.

Professor Carl Hart argues that societal acceptance of drugs is linked to social class. Psychedelics are becoming hip because they're used by the educated elite, while drugs like heroin and meth remain stigmatized as they are associated with lower socioeconomic classes and marginalized groups.

Proponent Max Marchione argues the debate isn't between using peptides or not, but between an unsafe gray market and a regulated 'white market.' He contends that since people already use them, legalizing their production in GMP-certified facilities under FDA oversight is the safest path forward to reduce net harm.